Dr Julie Louise Gerberding was the first woman to serve as director of the Centers for Disease Control, as well as leading the vaccine division at Merck for ... Roche vet joins two boards.

Merck & Co., Inc. operates as a healthcare company worldwide ... The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management ...

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...

Merck & Co., Inc. (NYSE:MRK) is a U.S.-based pharmaceutical company that focuses on producing vaccines and providing hospital care services. Its top-selling cancer drug, Keytruda, is a standout ...

Merck (NYSE:MRK) announced Wednesday that its 21-valent pneumococcal vaccine, Capvaxive, approved in the U.S. to prevent pneumonia, generated positive immune responses in a Phase 3 trial for ...

Merck (MRK) reachead $106.64 at the closing of the latest trading day, reflecting a +0.28% change compared to its last close. Visa, Netflix, Merck and Hovnanian are included in this Analyst Blog ...

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.

As of 11:24 am GMT-4. Market open.